You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
招銀國際:錦欣生殖(1951.HK)分紅1.5億元人民幣 維持買入評級
格隆匯 04-04 17:57

招銀國際發研報稱,維持錦欣生殖(1951.HK)“買入”評級及目標價19.01港元。2021年營收18.39億元,同比增長28.9%;可歸屬淨利潤3.54億元,同比增長35.8%,經調整的非國際財務報吿準則可歸屬淨利潤4.55億元,同比增長22.3%。收益高於該行預期。按業務劃分,ARS收入同比增長18.6%,至2021年11.6億元,主要得益於深圳中山醫院41.7%的收入增長。2021年在併購上獲益頗豐,公司於2021年11月以30億元人民幣收購四川錦欣婦女兒童醫院,並於2021年8月收購香港RHC和ARC。該行預計,2022年度收入將增長44%,其中15%的增長將歸因於公司的合併。另外,公司派息0.0738港元/股,以25億股份計算,共分紅1.845億港元(合人民幣1.5億元)。

錦欣生殖的婦兒業務整合初見成效。隨着業務集成的進展,該行預計會有更強的協同效應。另外,2022年1月,錦欣宣佈增持深圳中山醫院股份,從79.4%增至94.4%,使得在深圳中山醫院提供覆蓋婦產科、兒科和男科服務的,以輔助生殖為核心的全週期生育服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account